Abstract
To study the expression of intercellular adhesion molecule-1 (ICAM-1) by non-Hodgkin's lymphomas and to assess its correlation with disease extension and prognosis. ICAM-1 (CD54-IOL54) expression was studied in 70 patients (35 male/35 female; median age, 56 years) with non-Hodgkin's lymphoma from a single institution. Immunostaining was performed using a streptavidine-biotin alkaline phosphatase method and ICAM-1 expression was evaluated in a semiquantitative manner. The histologic distribution of the cases was the following: small lymphocytic, five cases; follicular, 14; mantle cell, five; diffuse large cell, 41; and T lymphoblastic, five. Forty patients (57%) were in stage IV, bulky disease was observed in 25 patients (36%), and extranodal involvement in 48 patients (69%). ICAM-1 expression was negative (-) in 14 patients (20%), weak (+) in 21 (30%), positive (++) in 30 (43%), and strongly positive ( ) in five (7%). No significant relationship was found between ICAM-1 expression and the lymphoma histologic subtype. Patients with negative or weak ICAM-1 expression had more frequently disseminated (stage IV) disease (74% v 40%; P = .007), extranodal involvement (86% v 51%; P = .004), and bone marrow infiltration (57% v 26%; P =...Continue Reading
Citations
May 26, 1999·Leukemia & Lymphoma·M Pérez-EncinasJ L Bello
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J TerolE Montserrat
Jul 13, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A CuneoG Castoldi
Jul 9, 2013·International Journal of Cancer. Journal International Du Cancer·Marloes L de GrooteMarianne G Rots
Jan 21, 2017·BMC Genomics·Anastasiya Vladimirovna SnezhkinaAnna Viktorovna Kudryavtseva
Mar 18, 2020·Journal of Leukocyte Biology·Triet M BuiRonen Sumagin
Mar 10, 2001·Medical and Pediatric Oncology·N YarisH Canpinar
Jun 1, 1999·Leukemia & Lymphoma·Y St-PierreE F Potworowski
Oct 21, 2006·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·D M MatosR P Falcão
Apr 11, 2009·International Journal of Hematology·Kazushi TanimotoMasaki Yasukawa
Apr 29, 2010·Current Hematologic Malignancy Reports·Jason R Westin, Luis E Fayad
Aug 18, 2018·British Journal of Cancer·Christoph KrispMark P Molloy
Jul 9, 2020·Journal of Cutaneous Pathology·Antonio Subtil, Alejandro A Gru
May 7, 2020·Cancers·Laia SadeghiAnthony P Wright
Jan 12, 2002·Nature Medicine·Margaret A ShippTodd R Golub
Jan 19, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Izidore S Lossos, Daniel Morgensztern
Mar 1, 2013·Blood·Assaf LaskYair Reisner
Apr 19, 2008·British Journal of Haematology·Johan LinderothEva Cavallin-Ståhl
Oct 16, 1999·Hematological Oncology·G A Young
Jun 22, 2005·Current Treatment Options in Oncology·Daniel Morgensztern, Izidore S Lossos
Nov 15, 2003·International Journal of Surgical Pathology·Paul TranchidaMargarita Palutke
Feb 11, 2021·Cancers·Kamila Duś-SzachniewiczJacek R Wiśniewski
Dec 9, 2020·Aging·Yizhen LiuQunling Zhang
Sep 23, 1998·Human Pathology·G K KoukoulisV E Gould
Sep 11, 2021·BMC Cancer·Wei WangBin Jiang
Aug 10, 2002·The Journal of Molecular Diagnostics : JMD·Ryan S RobetoryeKojo S J Elenitoba-Johnson